Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2005
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1600789A Promotive factor for activating NF-kappa B and usage
03/30/2005CN1600370A New chemical medicine in small molecule in use for curing dysmenorrhea and ache of bad rheumatoid arthritis
03/30/2005CN1600343A External remedy for curing scapulohumeral periarthritis
03/30/2005CN1600340A External remedy for curing pain of lower back and leg
03/30/2005CN1600339A A plaster for curing rheumatoid arthritis
03/30/2005CN1600333A Painkiller
03/30/2005CN1600331A Combination of Chinese traditional medicine possessing function of activating the channels and expelling rheumatism
03/30/2005CN1600304A Application of extractive of ussurian grape on curing inflammatory disease
03/30/2005CN1600299A Compound tablet of tramadol hydrochloride dispersion
03/30/2005CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/30/2005CN1194964C P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect
03/30/2005CN1194764C Use of radium-223 in preparing medicine for treating bone affected diseases
03/30/2005CN1194753C Medicine for treating head wind syndrome
03/30/2005CN1194743C Chinese medicinal composition for treating atrophic arthritis, preparing method and quality controlling method thereof
03/30/2005CN1194739C Medicine composition for treating cold and cough, and its prepn. method
03/30/2005CN1194728C Pellet capable of curing infantile anorexia and convulsion
03/30/2005CN1194718C Plaster for treating pains of neck, shoulder, waist and leg and prepn, process
03/30/2005CN1194712C Powerful pain-stopping aerosol
03/30/2005CN1194709C Kidney invigorating and bone strengthening medicine and its preparing method
03/30/2005CN1194700C Globeflower powder for injection and its prepn
03/30/2005CN1194696C Medicinal composition for injection, preparation containing said medicinal composition and its preparing process
03/30/2005CN1194689C Tetrahydropalmatine dispersion tablet for treating menalgia, and its prep no method
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872744 Analgesics
03/29/2005US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872733 Benzimidazolone compounds
03/29/2005US6872732 Heterocyclic derivatives and medicinal use thereof
03/29/2005US6872730 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
03/29/2005US6872725 Crystallized p38 kinase inhibitors for treatment of rheumatoid arthritis
03/29/2005US6872721 Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione
03/29/2005US6872719 Antiinflammatory agents; autoimmune disease
03/29/2005US6872709 Using glycyrrhizin
03/29/2005US6872702 Cyclic peptide; antitumor agents; antiinflammatory agents; tissue remodeling
03/29/2005CA2335186C Pyrrolo[2,3-d]pyrimidine compounds
03/29/2005CA2261760C Sulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/29/2005CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
03/24/2005WO2005026163A1 Dioxolane derivatives as cell adhesion inhibitors
03/24/2005WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR
03/24/2005WO2005026124A1 2-pyridone derivatives as netrophil elastase inhibitors and their use
03/24/2005WO2005026123A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use
03/24/2005WO2005026120A1 Matrix metalloproteinase inhibitors
03/24/2005WO2005026113A1 1, 3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases
03/24/2005WO2005025675A1 Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
03/24/2005WO2005025608A1 Ifn-ϝ for treatment of diseases associated with malfunction of the nod2 gene
03/24/2005WO2005025607A1 Methods of stimulating innate immunity using cationic peptides
03/24/2005WO2005025600A1 Drug inhibiting mobilization of adhesive cells into peripheral blood
03/24/2005WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
03/24/2005WO2005025571A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
03/24/2005WO2005025560A1 Ophthalmic composition
03/24/2005WO2005025552A2 Protein binding compounds
03/24/2005WO2004110990A3 Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38
03/24/2005WO2004110379A3 A1 adenosine receptor antagonists
03/24/2005WO2004104015A3 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
03/24/2005WO2004087074A3 Process for making substituted pyrazoles
03/24/2005WO2004085384A8 Bis-aryl sulfonamides
03/24/2005WO2004040302A8 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1
03/24/2005WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases
03/24/2005WO2004000204A3 Labelled somatostatin analogs backbone cyclized through metal complexation
03/24/2005WO2003104407A3 T cell receptor cdr3 sequences and methods for detection
03/24/2005WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
03/24/2005US20050065340 Psychological disorders; anxiolytic agents; antidepressants; analgesics ; schizophrenia
03/24/2005US20050065328 Gastrokines and derived peptides including inhibitors
03/24/2005US20050065325 Monoclonal antibody for use as diagnostic and therapeutic tool in treatment and prevention of cell proliferative and degenerative bone disorders
03/24/2005US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders
03/24/2005US20050065216 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065188 Aryl or heteroaryl amide compounds
03/24/2005US20050065155 Autoimmune disease ; antiinflammatory agents; antiischemic agents; rheumatic diseases; antiarthritic agents
03/24/2005US20050065153 Antiinflamamtory agents; respiratory system disorders; autoimmune disease
03/24/2005US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors
03/24/2005US20050065112 Antiproliferative agents; low toxicity; psoriasis; antitumor agents; rheumatic arthritis; gastrointestinal disorders; antiinflamamtory agents
03/24/2005US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents
03/24/2005US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases
03/24/2005US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases
03/24/2005US20050064543 Secreted proteins
03/24/2005US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders
03/24/2005US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics
03/24/2005US20050064409 Chp for use as marker for sepsis-type inflammatory diseases
03/24/2005US20050064014 Use of cystathionine
03/24/2005US20050063969 Assay
03/24/2005US20050063943 Conjugated of hydroxyalkyl starch and an active agent
03/24/2005CA2538416A1 A pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti inflammatory drug.
03/24/2005CA2538410A1 2-pyridone derivatives as netrophil elastase inhibitors and their use
03/24/2005CA2538315A1 Matrix metalloproteinase inhibitors
03/24/2005CA2538069A1 Effectors of innate immunity determination
03/23/2005EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor
03/23/2005EP1516881A2 Composition and method for modulating dendritic Cell-T cell interaction
03/23/2005EP1516866A1 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
03/23/2005EP1516631A1 Body ointment having decongestant effect and for the progressive relief of muscular pain, sprains, wrenchs, dislocations, aches and for relief of articular and rheumatic pain
03/23/2005EP1516627A1 Interferon-Gamma for the treatment of diseases associated with the NOD2 gene
03/23/2005EP1516621A2 Use of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of cell proliferation diseases
03/23/2005EP1516620A1 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
03/23/2005EP1516064A2 Methods of using 46828, a human acyl-coa synthetase
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
1 ... 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 ... 1272